Kpcb Dgf Associates Lowers stake in Teladoc Inc (TDOC)

Teladoc Inc (TDOC) : Kpcb Dgf Associates reduced its stake in Teladoc Inc by 67.42% during the most recent quarter end. The investment management company now holds a total of 1,087,086 shares of Teladoc Inc which is valued at $16,610,674 after selling 2,250,000 shares in Teladoc Inc , the firm said in a disclosure report filed with the SEC on Jul 8, 2016.Teladoc Inc makes up approximately 11.32% of Kpcb Dgf Associates’s portfolio.

Other Hedge Funds, Including , Bnp Paribas Arbitrage Sa added TDOC to its portfolio by purchasing 810 company shares during the most recent quarter which is valued at $12,377.

Teladoc Inc opened for trading at $16.29 and hit $16.4 on the upside on Wednesday, eventually ending the session at $16.14, with a gain of 0.94% or 0.15 points. The heightened volatility saw the trading volume jump to 4,92,108 shares. Company has a market cap of $625 M.

On the company’s financial health, Teladoc Inc reported $-0.40 EPS for the quarter, missing the analyst consensus estimate by $ -0.02 based on the information available during the earnings call on May 10, 2016. Analyst had a consensus of $-0.38. The company had revenue of $26.90 million for the quarter, compared to analysts expectations of $26.64 million. The company’s revenue was up 63.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $-5.87 EPS.

Many Wall Street Analysts have commented on Teladoc Inc. Company shares were Reiterated by Piper Jaffray on Jul 11, 2016 to “Overweight”, Firm has raised the Price Target to $ 22 from a previous price target of $20 .Teladoc Inc was Initiated by Piper Jaffray to “Overweight” on May 26, 2016.

Teladoc Inc. is a telehealth company. The Company offers an on-demand healthcare platform through mobile devices Internet video and phone. Its solution connects consumers with physicians and behavioral health professionals or its providers who treat various conditions and cases from acute diagnoses such as upper respiratory infection urinary tract infection and sinusitis to dermatological conditions anxiety and smoking cessation. The Teladoc solution enables accessing on-demand healthcare for employers health plans and health systems. Its platform provides accessing physicians clinical programs and consumer engagement strategies. Its platform provides for interconnectivity between healthcare constituents. It offers solutions such as remote patient monitoring post-discharge treatment plan adherence and in-home and chronic care. Its customers also include channel partners such as brokers resellers and consultants who sell into a range of small medium and large enterprises.

Leave a Reply

Teladoc Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Teladoc Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.